Resumen

VALLE RODRIGUEZ, E. et al. Cervical lymphangioma: therapeutic management with OK-432 (Picibanil). Rev Esp Cirug Oral y Maxilofac [online]. 2007, vol.29, n.6, pp.399-403. ISSN 2173-9161.

Introduction: Lymphangioma is a malformation of the lymphatic system. The classic approach is surgery. OK-432 (Picibanil) has sclerosing action and is being used as the first therapeutic step. The objective was to report a new case of lymphangioma treated with OK-432 and to review the literature. Material and method: We report the case of a 16-year-old man with a 10x6-cm macrocystic cervical lymphangioma treated with a dose of OK-432. Results: At 16 weeks of treatment, the size of the lymphangioma was 6x2 cm and it was clinically unappreciable. Discussion: OK-432 treatment has a high cure rate, low recurrence rate, and fibrosis circumscribed to the lesion. Compared to surgery, scars and possible harm to vital structures are avoided.

Palabras clave : Lymphangioma; Sclerosis; OK-432; Picibanil.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )